Health
Vaccine experts meeting over clot report – The Young Witness
A Melbourne man’s rare blood clotting disorder, likely linked to the AstraZeneca COVID-19 vaccine, will not affect its rollout to Australians. The Therapeutic……
A Melbourne man’s rare blood clotting disorder, likely linked to the AstraZeneca COVID-19 vaccine, will not affect its rollout to Australians.
The Therapeutic Goods Administration and Australian Technical Advisory Group on Immunisation met on Saturday morning and Acting Chief Medical Officer Michael Kidd said no changes to the AstraZeneca rollout were recommended.
He said it was likely, given similarities with rare overseas cases, that the man’s clotting disorder was related to him receiving the…
-
Business12 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business16 hours agoThis leading broker thinks the CSL share price can climb 40%
-
Business8 hours agoDicker Data rides the AI trend to double digit growth
-
Business11 hours agoForget CBA shares, this ASX 200 financials stock could be a better buy